Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy (Q57571544)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

M van Glabbeke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

J Verweij

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

A Le Cesne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

I Judson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

A T van Oosterom

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

J W Oosterhuis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

O S Nielsen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

64-69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900480-X

7 January 2021

Cyvadic in advanced soft tissue sarcoma: A randomized study comparing two schedules: A study of the EORTC soft tissue and bone sarcoma group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900480-X

7 January 2021

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900480-X

7 January 2021

Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900480-X

7 January 2021

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900480-X

7 January 2021

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900480-X

7 January 2021

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900480-X

7 January 2021

The outcome of advanced soft tissue sarcoma patients with complete tumour regression after either chemotherapy alone or chemotherapy plus surgery. The Scandinavian Sarcoma Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900480-X

7 January 2021

Preoperative induction chemotherapy in the treatment of locally advanced soft tissue sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900480-X

7 January 2021

High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900480-X

7 January 2021

Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900480-X

7 January 2021

10.1016/S0959-8049(02)00480-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504660%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference